Unknown

Dataset Information

Treatment of Fabry Disease: Established and Emerging Therapies.


ABSTRACT: Fabry disease (FD) is a rare, X-linked inherited disorder of glycosphingolipid metabolism. It leads to the progressive accumulation of globotriaosylceramide within lysosomes due to a deficiency of α-galactosidase A enzyme. It involves multiple organs, predominantly the renal, cardiac, and cerebrovascular systems. Early diagnosis and treatment are critical to prevent progression to irreversible tissue damage and organ failure, and to halt life-threatening complications that can significantly reduce life expectancy. This review will focus on the established and emerging treatment options for FD.

SUBMITTER: Umer M 

PROVIDER: S-EPMC9967779 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature